Light Sciences Oncology, Inc. Wins Therapeutic Discovery Grants Totaling $488,958 from the U.S. Government for Development of Aptocine in Liver Cancer and BPH

BELLEVUE, Wash.--(BUSINESS WIRE)--Light Sciences Oncology, Inc. (LSO) today announced that it has received two grants totaling $244,479 each from the U.S. Treasury under the Qualifying Therapeutic Discovery Project tax credit program, an economic stimulus package for small biopharmaceutical companies created by the Patient Protection and Affordable Care Act of 2010. Cash grants were awarded based on a competitive application process after evaluation by the National Institutes of Health and the Internal Revenue Service.

Back to news